Public Comment of Robert Hunter, Veteran

 

Review of the Health Effects in Vietnam Veterans of Exposure to Herbicides

Eleventh Biennial Update, Meeting 4, November 30, 2017

 

Under VA law, MGUS is a “disability” (because it is a disease)

International Classification of Diseases (ICD-10) Code D47.2

Not merely a lab finding, MGUS reduces life expectancy

Like the subclinical form of the Agent Orange (AO) presumptive disease, hypothyroidism, MGUS may be asymptomatic and noncompensable

Like other AO presumptive diseases, the prevalence of MGUS increases with age, e.g., type 2 diabetes, ischemic heart disease, and prostate cancer

 

MGUS is a precursor to the following AO presumptive diseases:

Multiple myeloma (MM is preceded by MGUS 100% of the time)

Non-Hodgkin’s lymphoma (WM is often preceded by IgM subtype of MGUS)

AL amyloidosis (AL is preceded by MGUS 100% of the time)

MGUS may precede chronic lymphocytic leukemia (CLL is another AO disease)

 

Operation Ranch Hand findings establish a positive association and increased risk

Show exposure to Agent Orange more than doubles the risk of MGUS

Suggest higher dioxin levels in blood fat increases MGUS risk

Show that even comparison Veterans had been exposed to dioxin

Support previous findings of pesticides/herbicides increasing MGUS risk

Support MGUS as having a key role in the pathway to multiple myeloma

Support an association between Agent Orange exposure and multiple myeloma

 

MGUS is associated with chronic immune system stimulation/dysregulation

Dioxin stored in the bodies of Veterans increases MGUS risk

Infections increase MGUS risk

Autoimmune diseases increase MGUS risk

Inflammation increases MGUS risk

A reasonable doubt about service connection is resolved in favor of the claimant

 

Monitoring for MGUS progression and MGUS complications

Typically MGUS is diagnosed incidentally

Lifelong monitoring after MGUS diagnosis is the standard of care

Can give an early warning of diseases like asymptomatic AL amyloidosis

Associated with longer survival in multiple myeloma

Allows better management of potential complications of MGUS, e.g., kidney damage, infections, neuropathy, blood clots

High BMI is associated with increased risk of progression, MM

Dioxin half-life in humans is 7.6 years; increases with body fat and age

VA can waive copayments for MGUS-related care of dioxin-exposed Veterans

 

Offering MGUS screening to Veterans exposed to dioxin?

Most MGUS does not progress to cancer

Would help Veterans quantify their risks of progression and take action

A MGUS diagnosis may cause anxiety

VA to decide how to balance these issues

 

Evidence supporting the above statements is attached.